Physician

Christopher Sang Don Lee, M.D.

According to 2025 Medicare claims, Christopher Lee, M.D. (NPI: 1013901693) practices urology in the Vineland, NJ market, with the plurality of this provider's patient population coming from Cumberland, NJ. This provider's primary affiliated billing organization is SOUTH JERSEY UROLOGY CONSULTANTS LLC (NPI: 1740428846; TIN: 263697129) and primary practice location at 08360-6933.

Lee's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 647 traditional Medicare patients, billed 17,216 HCPCS/CPT codes, and received $1,045,607 in Medicare payments. The top billing code was 93975 (Complete ultrasound of abdomen and pelvis artery and vein blood flow). Part D data shows 5,611 prescription claims across 1,099 beneficiaries totaling $805,348 in drug costs, led by Xtandi (Enzalutamide). DME data shows 33 claims. Open Payments data shows 46 records totaling $841. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	794	23,512	$1,170,645
2016	849	25,006	$1,142,637
2017	857	15,411	$824,239
2018	841	15,622	$844,160
2019	764	13,893	$883,104
2020	610	9,299	$644,880
2021	651	8,376	$740,818
2022	657	11,489	$878,765
2023	698	16,284	$887,284
2024	647	17,216	$1,045,607

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	581	2,821	$395,486
2016	616	2,861	$352,365
2017	553	2,410	$321,928
2018	550	2,413	$340,537
2019	636	2,962	$301,399
2020	643	2,922	$302,902
2021	736	3,291	$359,271
2022	823	3,494	$403,804
2023	972	4,477	$472,846
2024	1,099	5,611	$805,348

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	18	80	$7,210
2016	11	71	$8,674
2017	N/R	23	$6,370
2018	N/R	101	$9,359
2019	11	121	$8,084
2020	N/R	103	$14,349
2021	N/R	100	$12,613
2022	N/R	82	$11,826
2023	N/R	79	$16,031
2024	N/R	33	$11,118

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93975	Complete ultrasound of abdomen and pelvis artery and vein blood flow	336	404	$209
93976	Ultrasound of abdomen and pelvis artery and vein blood flow	215	231	$101
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	542	1,119	$97
76770	Complete ultrasound scan behind abdominal cavity	244	254	$89
76775	Limited ultrasound scan behind abdominal cavity	283	292	$44

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	22	660	$318,812
Myrbetriq	Mirabegron	238	18,164	$261,971
Alfuzosin Hcl Er	Alfuzosin Hcl	1,916	163,931	$58,310
Gemtesa	Vibegron	56	3,702	$57,791
Finasteride	Finasteride	1,423	121,483	$23,221

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	22	$10,763
A4358	Urinary drainage bag, leg or abdomen, vinyl, with or without tube, with straps, each	N	N/R	11	$355

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	46	$841	Sumitomo Pharma America, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Christopher Sang Don Lee, M.D.?

Tedicare shows public-source Medicare data for Christopher Sang Don Lee, M.D. (NPI 1013901693), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher Sang Don Lee, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Christopher Sang Don Lee, M.D.?

Christopher Sang Don Lee, M.D. is linked to SOUTH JERSEY UROLOGY CONSULTANTS LLC (billing NPI 1740428846) in the available physician profile data.

Does Christopher Sang Don Lee, M.D. have Open Payments data?

Christopher Sang Don Lee, M.D. has 46 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.